Chinese scientists successfully transplanted a genetically modified pig liver into a brain-dead human, marking a significant step in xenotransplantation. The pig liver showed no signs of rejection and produced bile and albumin, but its long-term viability remains uncertain. This research aims to address organ shortages for patients with liver failure, potentially serving as a temporary 'bridge therapy' until a permanent transplant can be secured.